Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cody Ashby

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|July 10, 2021
High-risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapseEileen M Boyle, Adam Rosenthal, Yan Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 4, 2026
Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cellsHayley M Sabol, Bethany C Paxton, Aric Anloague, et al.
Blood Cancer Journal|February 14, 2024
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systemsWancheng Guo, Yihao Zhan, David Mery, et al.
Blood Cancer Journal|November 6, 2024
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stagesYan Cheng, Fumou Sun, Daisy V Alapat, et al.
The Journal of Clinical Investigation|July 26, 2022
CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiationDongzheng Gai, Jin-Ran Chen, James P Stewart, et al.
Blood Cancer Journal|June 20, 2020
Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patternsCarolina Schinke, Eileen M Boyle, Cody Ashby, et al.
Haematologica|May 28, 2017
The level of deletion 17p and bi-allelic inactivation of <i>TP53</i> has a significant impact on clinical outcome in multiple myelomaSharmilan Thanendrarajan, Erming Tian, Pingping Qu, et al.
Journal of Hematology & Oncology|June 29, 2023
A gene signature can predict risk of MGUS progressing to multiple myelomaFumou Sun, Yan Cheng, Jun Ying, et al.
Cancers|March 28, 2024
A Risk Stratification System in Myeloma Patients with Autologous Stem Cell TransplantationWancheng Guo, Christopher Strouse, David Mery, et al.
Genome Research|December 22, 2021
Epigenomic translocation of H3K4me3 broad domains over oncogenes following hijacking of super-enhancersAneta Mikulasova, Daniel Kent, Marco Trevisan-Herraz, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|July 10, 2021
High-risk transcriptional profiles in multiple myeloma are an acquired feature that can occur in any subtype and more frequently with each subsequent relapseEileen M Boyle, Adam Rosenthal, Yan Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 4, 2026
Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cellsHayley M Sabol, Bethany C Paxton, Aric Anloague, et al.
Blood Cancer Journal|February 14, 2024
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systemsWancheng Guo, Yihao Zhan, David Mery, et al.
Blood Cancer Journal|November 6, 2024
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stagesYan Cheng, Fumou Sun, Daisy V Alapat, et al.
The Journal of Clinical Investigation|July 26, 2022
CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiationDongzheng Gai, Jin-Ran Chen, James P Stewart, et al.
Blood Cancer Journal|June 20, 2020
Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patternsCarolina Schinke, Eileen M Boyle, Cody Ashby, et al.
Haematologica|May 28, 2017
The level of deletion 17p and bi-allelic inactivation of <i>TP53</i> has a significant impact on clinical outcome in multiple myelomaSharmilan Thanendrarajan, Erming Tian, Pingping Qu, et al.
Journal of Hematology & Oncology|June 29, 2023
A gene signature can predict risk of MGUS progressing to multiple myelomaFumou Sun, Yan Cheng, Jun Ying, et al.
Cancers|March 28, 2024
A Risk Stratification System in Myeloma Patients with Autologous Stem Cell TransplantationWancheng Guo, Christopher Strouse, David Mery, et al.
Genome Research|December 22, 2021
Epigenomic translocation of H3K4me3 broad domains over oncogenes following hijacking of super-enhancersAneta Mikulasova, Daniel Kent, Marco Trevisan-Herraz, et al.
Pageof 6